Comparative/JJ
Genomics/NNS
Study/NN
of/IN
Interferon-a/NN
Receptor-1/NN
in/IN
Humans/JJ
and/CC
Chimpanzees/NNS
./.
====================
The/DT
immune/JJ
response-related/JJ
genes/NNS
have/VBP
been/VBN
suggested/VBN
to/TO
be/VB
the/DT
most/JJS
favorable/JJ
genes/NNS
for/IN
positive/JJ
selection/NN
during/IN
evolution/NN
./.
====================
Comparing/VBG
the/DT
entire/JJ
DNA/NN
sequence/NN
of/IN
chimpanzee/NN
chromosome/NN
22/CD
(/(
PTR22/NN
)/)
with/IN
human/JJ
chromosome/NN
21/CD
(/(
HSA21/NN
)/)
,/,
we/PRP
have/VBP
identified/VBN
15/CD
orthologs/NNS
having/VBG
indel/NN
in/IN
their/PRP$
coding/VBG
sequences/NNS
./.
====================
Among/IN
them/PRP
,/,
interferon-a/NN
receptor-1/NN
gene/NN
(/(
IFNAR1/NN
)/)
,/,
an/DT
immune-/NN
response-related/VBD
gene/NN
,/,
is/VBZ
subjected/VBN
to/TO
comparative/JJ
genomic/JJ
analysis/NN
./.
====================
Chimpanzee/NN
IFNAR1/NN
showed/VBD
the/DT
same/JJ
genomic/JJ
structure/NN
as/IN
human/JJ
IFNAR1/NN
(/(
11/CD
exons/NNS
and/CC
10/CD
introns/NNS
)/)
except/IN
the/DT
3/CD
bp/NN
insertion/NN
in/IN
exon/NN
4/CD
./.
====================
The/DT
sequence/NN
alignment/NN
of/IN
IFNAR1/NN
coding/VBG
sequence/NN
indicated/VBD
that/IN
“/CD
ISPP/NN
”/CD
amino/NN
acid/NN
sequence/NN
motif/NN
is/VBZ
highly/RB
conserved/VBN
in/IN
chimpanzee/NN
and/CC
other/JJ
animals/NNS
including/VBG
mouse/NN
and/CC
chicken/NN
./.
====================
However/RB
,/,
the/DT
human/JJ
IFNAR1/NN
shows/VBZ
that/IN
one/CD
proline/NN
residue/NN
is/VBZ
missing/JJ
in/IN
the/DT
sequence/NN
motif/NN
./.
====================
The/DT
homology/NN
modeling/VBG
of/IN
the/DT
IFNAR1/NN
structures/NNS
suggests/VBZ
that/IN
the/DT
proline/NN
deletion/NN
in/IN
human/JJ
IFNAR1/NN
leads/VBZ
to/TO
the/DT
formation/NN
of/IN
the/DT
following/VBG
a-helix/JJ
,/,
whereas/IN
two/CD
sequential/JJ
prolines/NNS
in/IN
chimpanzee/NN
IFNAR1/NN
inhibit/VBP
it/PRP
./.
====================
As/IN
a/DT
result/NN
,/,
human/JJ
IFNAR1/NN
may/MD
adopt/VB
a/DT
characteristic/JJ
structure/NN
distinct/JJ
from/IN
chimpanzee/NN
IFNAR1/NN
./.
====================
This/DT
human/JJ
specific/JJ
trait/NN
could/MD
contribute/VB
to/TO
specific/JJ
immune/JJ
response/NN
in/IN
the/DT
most/JJS
optimized/VBN
manner/NN
for/IN
humans/NNS
./.
====================
Further/RB
molecular/JJ
biological/JJ
studies/NNS
on/IN
the/DT
IFNAR1/NN
will/MD
help/VB
us/PRP
to/TO
gain/VB
insights/NNS
into/IN
the/DT
molecular/JJ
implication/NN
of/IN
species­/JJ
specific/JJ
host-pathogen/NN
interaction/NN
in/IN
primate/JJ
evolution/NN
./.
====================
Recently/RB
,/,
we/PRP
reported/VBD
the/DT
entire/JJ
DNA/NN
sequence/NN
of/IN
the/DT
euchromatic/JJ
region/NN
of/IN
chimpanzee/NN
chromosome/NN
22/CD
(/(
PTR22/NN
)/)
(/(
Watanabe/NNP
etal./FW
,/,
2004/CD
)/)
./.
====================
The/DT
data/NNS
allowed/VBD
us/PRP
to/TO
search/VB
for/IN
the/DT
differences/NNS
in/IN
nucleotide/NN
sequence/NN
between/IN
human/JJ
and/CC
chimpanzee/NN
./.
====================
Compared/VBN
with/IN
human/JJ
chromosome/NN
21/CD
(/(
HSA21/NN
)/)
,/,
PTR22/NN
differs/VBZ
at/IN
approximately/RB
1.44/CD
%/NN
of/IN
their/PRP$
33/CD
million/NN
aligned/VBD
nucleotides/NNS
./.
====================
In/IN
addition/NN
,/,
15/CD
orthologs/NNS
among/IN
the/DT
231/CD
orthologous/JJ
genes/NNS
on/IN
PTR22/NN
,/,
were/VBD
identified/VBN
to/TO
have/VB
indels/VBZ
within/IN
their/PRP$
coding/VBG
sequences/NNS
./.
====================
The/DT
indels/NNS
on/IN
the/DT
coding/VBG
sequences/NNS
would/MD
potentially/RB
lead/VBP
to/TO
gross/JJ
structural/JJ
changes/NNS
on/IN
protein/NN
./.
====================
It/PRP
was/VBD
hypothesized/VBN
that/IN
indels/VBZ
may/MD
represent/VB
one/CD
of/IN
the/DT
major/JJ
mechanisms/NNS
of/IN
proteome/JJ
evolution/NN
in/IN
the/DT
higher/JJR
primates/NNS
(/(
Watanabe/NNP
etal./FW
,/,
2004/CD
)/)
./.
====================
In/IN
terms/NNS
of/IN
evolution/NN
,/,
IFNAR1/NN
among/IN
the/DT
15/CD
orthologs/NNS
is/VBZ
especially/RB
interesting/JJ
because/IN
the/DT
immune-response-related/JJ
genes/NNS
have/VBP
been/VBN
suggested/VBN
to/TO
be/VB
the/DT
most/JJS
favorable/JJ
genes/NNS
for/IN
positive/JJ
selection/NN
during/IN
evolution/NN
(/(
Endo/NN
et/FW
al./FW
,/,
1996/CD
;/:
Hughes/NNS
,/,
1997/CD
;/:
Sawyer/NNP
etal./FW
,/,
2004/CD
)/)
./.
====================
The/DT
IFNAR1/NN
gene/NN
belongs/VBZ
to/TO
the/DT
class/NN
II/CD
cytokine/NN
receptor/NN
family/NN
(/(
Gibbs/NNS
etal./FW
,/,
1996/CD
;/:
Oritani/NNP
etal./FW
,/,
2001/CD
)/)
./.
====================
The/DT
human/JJ
interferon-a/NN
receptor/NN
is/VBZ
a/DT
multi-chain/JJ
receptor/NN
complex/NN
which/WDT
binds/VBZ
the/DT
multiple/JJ
human/JJ
type/NN
I/CD
interferons/NNS
with/IN
high/JJ
affinity/NN
in/IN
a/DT
species-specific/JJ
manner/NN
./.
====================
IFNAR1/NN
encodes/VBZ
one/CD
chain/NN
of/IN
the/DT
receptor/NN
protein/NN
(/(
hlFN-aR/NN
)/)
,/,
which/WDT
contains/VBZ
an/DT
extracellular/JJ
domain/NN
of/IN
409/CD
amino/NN
acids/NNS
,/,
a/DT
single/JJ
transmembrane/JJ
domain/NN
of/IN
21/CD
amino/NN
acids/NNS
,/,
and/CC
an/DT
IC/NN
domain/NN
of/IN
100-amino/DT
acids/NNS
./.
====================
Mice/NNS
in/IN
which/WDT
the/DT
gene/NN
for/IN
IFNAR1/NN
has/VBZ
been/VBN
inactivated/VBN
by/IN
homologous/JJ
recombination/NN
are/VBP
unresponsive/JJ
to/TO
all/DT
type/NN
I/CD
interferons/NNS
and/CC
are/VBP
unable/JJ
to/TO
mount/VB
an/DT
effective/JJ
antiviral/JJ
defense/NN
(/(
Muller/NNP
etal./FW
,/,
1994/CD
;/:
Hwang/NNP
etal./FW
,/,
1995/CD
)/)
./.
====================
These/DT
findings/NNS
suggest/VBP
that/IN
IFNAR1/NN
is/VBZ
a/DT
signal-/JJ
transducing/VBG
chain/NN
of/IN
the/DT
multi-component/JJ
receptor/NN
complex/NN
that/WDT
has/VBZ
low/JJ
affinity/NN
binding/NN
for/IN
most/JJS
IFN-a/JJ
subspecies/NNS
and/CC
is/VBZ
essential/JJ
for/IN
type/NN
I/CD
interferon/NN
mediated/VBN
responses/NNS
./.
====================
Type/NN
I/CD
interferons/NNS
induce/VBP
the/DT
transcription/NN
of/IN
interferon-stimulated/JJ
genes/NNS
through/IN
the/DT
formation/NN
and/CC
activation/NN
of/IN
ISRE-/NN
binding/NN
proteins/NNS
./.
====================
Many/JJ
interferon-stimulated/JJ
genes/NNS
play/VBP
roles/NNS
in/IN
antiviral/JJ
responces/VBZ
via/IN
innate/JJ
immune/JJ
mechanism/NN
(/(
Asaoka/NN
etal./FW
,/,
2005/CD
;/:
Osiak/NN
etal./FW
,/,
2005/CD
)/)
./.
====================
In/IN
this-/JJ
study/NN
,/,
we/PRP
analyzed/VBD
and/CC
compared/VBD
genomic/JJ
structure/NN
of/IN
IFNAR1/NN
gene/NN
between/IN
human/JJ
and/CC
chimpanzee/NN
and/CC
discuss/VBP
its/PRP$
consequence/NN
on/IN
protein/NN
structure/NN
with/IN
implication/NN
of/IN
immune-response-related/JJ
====================
genes/NNS
in/IN
primate/JJ
evolution/NN
./.
====================
Genomic/JJ
organization/NN
of/IN
chimpanzee/NN
IFNAR1/NN
gene/NN
was/VBD
analyzed/VBN
and/CC
compared/VBN
with/IN
that/DT
of/IN
human/JJ
./.
====================
To/TO
understand/VB
the/DT
genomic/JJ
characteristics/NNS
of/IN
chimpanzee/NN
IFNAR1/NN
,/,
we/PRP
predicted/VBD
genomic/JJ
structure/NN
of/IN
chimpanzee/NN
====================
IFNAR1/NN
(/(
Ensenbl/NN
gene/NN
ID/NN
:/:
ENSPTRG00000013867/CD
)/)
====================
using/VBG
est2genome/NN
program/NN
(/(
Mott/NN
et/FW
al./FW
,/,
1997/CD
)/)
./.
====================
The/DT
program/NN
was/VBD
run/JJ
by/IN
matching/VBG
human/JJ
Ensembl/NN
gene/NN
(/(
ENSG00000142166/CD
)/)
as/IN
a/DT
query/RB
sequence/NN
to/TO
chimpanzee/NN
genomic/JJ
DNA/NN
sequence/NN
./.
====================
The/DT
chimpanzee/NN
IFNAR1/NN
(/(
ENSPTRG00000013867/CD
)/)
showed/VBD
the/DT
genomic/JJ
size/NN
of/IN
42,648/CD
bp/NN
and/CC
the/DT
same/JJ
gene/NN
structure/NN
as/IN
human/JJ
IFNAR1/NN
./.
====================
As/IN
shown/VBN
in/IN
Fig.1/NN
,/,
human/JJ
and/CC
chimpanzee/NN
IFNARIs/NNS
are/VBP
composed/VBN
of/IN
11/CD
exons/NNS
and/CC
10/CD
introns/NNS
./.
====================
The/DT
obvious/JJ
difference/NN
between/IN
the/DT
two/CD
genes/NNS
is/VBZ
that/DT
chimpanzee/NN
IFNAR1/NN
has/VBZ
about/RB
8/CD
kb/NN
insertion/NN
between/IN
exon/NN
1/CD
and/CC
2/CD
./.
====================
Since/IN
upstream/JJ
sequences/NNS
from/IN
the/DT
transcription/NN
start/NN
site/NN
have/VBP
been/VBN
known/VBN
to/TO
be/VB
important/JJ
for/IN
gene/NN
regulation/NN
,/,
====================
we/PRP
analyzed/VBD
transcription/NN
factor/NN
binding/NN
sites/NNS
(/(
TFBS/NN
)/)
from/IN
the/DT
3/CD
kb/NN
upstream/RB
transcription/NN
start/NN
site/NN
of/IN
IFNAR1/NN
in/IN
both/DT
species/NNS
using/VBG
rVista/JJ
'/``
(/(
limited/JJ
vertebrate/JJ
TF/NN
,/,
Matrix/JJ
similarity/NN
0.95/CD
)/)
./.
====================
We/PRP
had/VBD
identified/VBN
35/CD
TFBS/NN
from/IN
the/DT
upstream/JJ
sequence/NN
of/IN
human/JJ
IFNAR1/NN
and/CC
confirmed/VBD
all/DT
of/IN
the/DT
TFBSs/NNS
are/VBP
conserved/VBN
in/IN
chimpanzee/NN
genome/NN
(/(
Table/JJ
1/CD
)/)
suggesting/VBG
that/IN
the/DT
regulation/NN
of/IN
IFNAR1/NN
expression/NN
might/MD
is/VBZ
similar/JJ
in/IN
both/DT
the/DT
species/NNS
./.
====================
Next/RB
,/,
we/PRP
tried/VBD
to/TO
speculate/VB
the/DT
changes/NNS
in/IN
coding/VBG
sequence/NN
(/(
CDS/NNS
)/)
of/IN
human/JJ
IFNAR1/NN
caused/VBD
by/IN
the/DT
genomic/JJ
change/NN
./.
====================
As/IN
shown/VBN
in/IN
Fig/NN
./.
====================
2/CD
,/,
human/JJ
IFNAR1/NN
has/VBZ
9/CD
base/NN
substitution/NN
and/CC
3/CD
bp/NN
insertion/NN
in/IN
exon/NN
4/CD
./.
====================
The/DT
3/CD
bp/NN
insertion/NN
in/IN
exon/NN
4/CD
resulted/VBD
in/IN
the/DT
addition/NN
of/IN
amino/NN
acid/NN
proline/NN
at/IN
amino/NN
acid/NN
position/NN
149/CD
./.
====================
The/DT
4/CD
out/RB
of/IN
9/CD
base/NN
substitutions/NNS
led/VBD
to/TO
amino/NN
acid/NN
substitutions/NNS
of/IN
Val4Ala/NN
,/,
Thr68Pro/NN
,/,
Ala425Val/NN
and/CC
Ser478Asn/NN
./.
====================
IFNAR1/NN
provides/VBZ
a/DT
unique/JJ
example/NN
of/IN
cross-species/NNS
orthologs/NNS
in/IN
that/DT
they/PRP
are/VBP
from/IN
evolutionarily/RB
closed/VBN
primates/NNS
./.
====================
As/IN
most/JJS
of/IN
gene/NN
structures/NNS
are/VBP
almost/RB
identical/JJ
for/IN
primates/NNS
,/,
sequences/NNS
with/IN
such/JJ
striking/JJ
difference/NN
are/VBP
available/JJ
only/RB
in/IN
a/DT
few/JJ
cases/NNS
./.
====================
In/IN
this/DT
context/NN
,/,
the/DT
3/CD
bp/NN
indel/NN
in/IN
the/DT
orthologs/NNS
of/IN
IFNAR1/NN
is/VBZ
very/RB
exceptional/JJ
./.
====================
Thus/RB
,/,
species-specific/JJ
,/,
rapidly/RB
diverging/VBG
insertions/NNS
or/CC
deletions/NNS
may/MD
contribute/VB
to/TO
gene/NN
diversification/NN
during/IN
evolution/NN
./.
====================
Proline/NN
indel/NN
results/NNS
in/IN
structural/JJ
difference/NN
between/IN
human/JJ
and/CC
chimpanzee/NN
IFNARIs/NNS
====================
To/TO
determine/VB
whether/IN
the/DT
proline/NN
indel/NN
affects/VBZ
the/DT
====================
three-dimensional/JJ
structure/NN
of/IN
IFNAR1/NN
,/,
we/PRP
carried/VBD
out/RP
the/DT
homology/NN
modeling/VBG
of/IN
human/JJ
and/CC
chimpanzee/NN
IFNARIs/NNS
,/,
using/VBG
the/DT
program/NN
SwissModel/NN
./.
====================
The/DT
template/JJ
was/VBD
derived/VBN
from/IN
the/DT
crystal/JJ
structure/NN
of/IN
the/DT
extracellular/JJ
domain/NN
(/(
ECD/NN
)/)
in/IN
human/JJ
Interferon/NN
y/RB
receptor/NN
a/DT
chain/NN
(/(
PDB/NN
code/VBP
1/CD
FYH/NN
:/:
E/NN
)/)
(/(
Randal/JJ
etal./FW
,/,
2001/CD
)/)
./.
====================
The/DT
Interferon/NN
y/RB
receptor/NN
a/DT
chain/NN
shows/VBZ
28/CD
%/NN
identity/NN
and/CC
52/CD
%/NN
similarity/NN
of/IN
amino/NN
acid/NN
sequence/NN
with/IN
human/JJ
IFNAR1/NN
for/IN
the/DT
residues/NNS
60-128/CD
./.
====================
It/PRP
also/RB
has/VBZ
22/CD
%/NN
identity/NN
and/CC
44/CD
%/NN
similarity/NN
of/IN
sequence/NN
with/IN
chimpanzee/NN
IFNAR1/NN
for/IN
the/DT
residues/NNS
60-205/CD
./.
====================
The/DT
comparison/NN
of/IN
the/DT
modeled/JJ
structures/NNS
reveals/VBZ
the/DT
obvious/JJ
structural/JJ
difference/NN
in/IN
the/DT
vicinity/NN
of/IN
Pro149/NN
in/IN
the/DT
ligand/NN
binding/NN
domain/NN
of/IN
chimpanzee/NN
IFNAR1/NN
(/(
Fig/NN
./.
====================
4/CD
)/)
./.
====================
Fig/NN
./.
====================
4A/CD
shows/VBZ
the/DT
crystal/JJ
structure/NN
of/IN
the/DT
ECD/NN
in/IN
human/JJ
Interferon/NN
y/RB
receptor/NN
a/DT
chain/NN
./.
====================
In/IN
the/DT
structure/NN
,/,
Pro131/NN
of/IN
human/JJ
Interferon/NN
y/RB
receptor/NN
a/DT
chain/NN
corresponds/VBZ
to/TO
the/DT
site/NN
of/IN
the/DT
proline/NN
insertion/NN
in/IN
chimpanzee/NN
IFNAR1/NN
./.
====================
In/IN
the/DT
human/JJ
Interferon/NN
y/RB
receptor/NN
a/DT
chain/NN
,/,
Pro131/NN
serve/VBP
as/IN
connecting/VBG
the/DT
preceding/VBG
(/(
3-strand/CC
and/CC
the/DT
following/VBG
a-helix/JJ
,/,
kinking/VBG
the/DT
running/JJ
direction/NN
of/IN
the/DT
backbone/NN
./.
====================
In/IN
human/JJ
IFNAR1/NN
,/,
Pro148/NN
corresponds/VBZ
to/TO
Pro131/NN
of/IN
human/JJ
Interferon/NN
y/RB
receptor/NN
a/DT
chain/NN
,/,
playing/VBG
the/DT
same/JJ
role/NN
(/(
Fig/NN
./.
====================
4B/NN
)/)
./.
====================
On/IN
the/DT
other/JJ
hand/NN
,/,
in/IN
chimpanzee/NN
IFNAR1/NN
,/,
Pro149/NN
is/VBZ
inserted/VBN
at/IN
the/DT
same/JJ
position/NN
and/CC
thus/RB
two/CD
sequential/JJ
prolines/NNS
(/(
Pro148/NN
and/CC
Pro149/NN
)/)
are/VBP
present/JJ
(/(
Fig/NN
./.
====================
4C/NN
)/)
./.
====================
It/PRP
is/VBZ
interesting/JJ
to/TO
find/VB
that/IN
the/DT
following/VBG
a-helix/JJ
is/VBZ
not/RB
formed/VBN
due/JJ
to/TO
the/DT
presence/NN
of/IN
two/CD
sequential/JJ
prolines/NNS
./.
====================
We/PRP
====================
suggest/VBP
that/IN
the/DT
proline/NN
deletion/NN
in/IN
human/JJ
IFNAR1/NN
results/NNS
in/IN
the/DT
formation/NN
of/IN
the/DT
following/VBG
a-helix/JJ
,/,
changing/VBG
the/DT
conservation/NN
of/IN
secondary/JJ
structure/NN
pattern/NN
./.
====================
In/IN
addition/NN
to/TO
the/DT
proline/NN
indel/NN
,/,
there/EX
are/VBP
4/CD
amino/NN
acid/NN
substitutions/NNS
between/IN
human/JJ
and/CC
chimpanzee/NN
IFNARIs/NNS
./.
====================
The/DT
most/JJS
noticeable/JJ
one/CD
is/VBZ
the/DT
change/NN
from/IN
Thr68/NN
in/IN
human/JJ
IFNAR1/NN
to/TO
Pro68/NN
in/IN
chimpanzee/NN
IFNAR1/NN
(/(
Thr68Pro/NN
)/)
./.
====================
The/DT
residue/NN
68/CD
in/IN
IFNAR1/NN
corresponds/VBZ
to/TO
Tyr49/NN
of/IN
human/JJ
Interferon/NN
y/RB
receptor/NN
a/DT
chain/NN
./.
====================
The/DT
side-chain/JJ
oxygen/NN
atom/IN
of/IN
Tyr49/NN
was/VBD
observed/VBN
to/TO
form/VB
====================
the/DT
intermolecular/JJ
hydrogen/NN
bond/NN
with/IN
the/DT
side-chain/JJ
oxygen/NN
of/IN
Glu312/NN
in/IN
interferon/NN
y/RB
(/(
Randal/JJ
etal./FW
,/,
2001/CD
)/)
./.
====================
Therefore/RB
,/,
it/PRP
is/VBZ
likely/JJ
that/IN
the/DT
substitution/NN
at/IN
the/DT
position/NN
effects/NNS
on/IN
interferon/NN
y/RB
binding/NN
./.
====================
We/PRP
suggest/VBP
that/IN
Thr68/NN
in/IN
human/JJ
IFNAR1/NN
potentially/RB
forms/VBZ
the/DT
same/JJ
hydrogen/NN
bond/NN
as/IN
in/IN
human/JJ
Interferon/NN
y/RB
receptor/NN
but/CC
Pro68/NN
in/IN
chimpanzee/NN
IFNAR1/NN
can/MD
not/RB
since/IN
it/PRP
has/VBZ
no/DT
side-chain/JJ
oxygen/NN
atom/IN
capable/JJ
of/IN
making/VBG
hydrogen/NN
bonds/NNS
./.
====================
In/IN
addition/NN
,/,
Thr68/NN
may/MD
form/VB
the/DT
part/NN
of/IN
P-strand/NN
like/IN
in/IN
human/JJ
Interferon/NN
y/RB
receptor/NN
but/CC
Pro68/NN
can/MD
not/RB
since/IN
it/PRP
====================
has/VBZ
no/DT
main-chain/JJ
amide/NN
proton/NN
./.
====================
The/DT
other/JJ
substitutions/NNS
contain/VBP
Val4Ala/NN
,/,
Ala425Val/NN
,/,
and/CC
Ser478Asn/NN
./.
====================
These/DT
substitutions/NNS
are/VBP
not/RB
likely/JJ
to/TO
induce/VB
significant/JJ
alteration/NN
in/IN
the/DT
secondary/JJ
structure/NN
as/IN
the/DT
properties/NNS
of/IN
changed/JJ
amino/NN
acids/NNS
are/VBP
similar/JJ
./.
====================
Multiple/JJ
sequence/NN
alignment/NN
of/IN
IFNAR1/NN
from/IN
human/JJ
,/,
chimpanzee/NN
,/,
and/CC
other/JJ
animals/NNS
including/VBG
mouse/NN
,/,
rat/NN
and/CC
chicken/NN
,/,
indicated/VBD
that/IN
“/CD
ISPP/NN
”/CD
motif/NN
in/IN
the/DT
ligand/NN
binding/NN
domain/NN
of/IN
IFNAR1/NN
is/VBZ
highly/RB
conserved/VBN
in/IN
all/DT
of/IN
the/DT
other/JJ
animals/NNS
from/IN
chicken/NN
to/TO
chimpanzee/NN
(/(
Fig/NN
./.
====================
5/CD
)/)
./.
====================
The/DT
human/JJ
IFNAR1/NN
showed/VBD
that/IN
one/CD
proline/NN
residue/NN
is/VBZ
missing/JJ
in/IN
the/DT
segment/NN
,/,
implying/VBG
that/DT
the/DT
proline/NN
might/MD
be/VB
deleted/VBN
after/IN
divergence/NN
from/IN
common/JJ
ancestor/NN
of/IN
human/JJ
and/CC
chimpanzee/NN
during/IN
evolution/NN
./.
====================
It/PRP
is/VBZ
striking/JJ
to/TO
notice/RB
that/DT
this/DT
conserved/VBN
sequence/NN
motif/NN
is/VBZ
likely/JJ
to/TO
be/VB
the/DT
only/RB
region/NN
that/WDT
bears/VBZ
significant/JJ
difference/NN
between/IN
the/DT
human/JJ
and/CC
nonhuman/JJ
hominoids/NNS
./.
====================
Our/PRP$
homology/NN
modeling/VBG
study/NN
reveals/VBZ
the/DT
structural/JJ
difference/NN
between/IN
human/JJ
and/CC
chimpanzee/NN
IFNARIs/NNS
./.
====================
The/DT
proline/NN
deletion/NN
in/IN
human/JJ
IFNAR1/NN
leads/VBZ
to/TO
the/DT
formation/NN
of/IN
the/DT
following/VBG
a-helix/JJ
,/,
whereas/IN
two/CD
sequential/JJ
prolines/NNS
in/IN
chimpanzee/NN
IFNAR1/NN
inhibit/VBP
it/PRP
(/(
Fig/NN
./.
====================
4/CD
)/)
./.
====================
At/IN
present/JJ
,/,
the/DT
functional/JJ
implication/NN
of/IN
these/DT
differences/NNS
in/IN
the/DT
I/NN
FNAR/NN
1/CD
structure/NN
is/VBZ
not/RB
clear/JJ
./.
====================
However/RB
,/,
it/PRP
has/VBZ
been/VBN
reported/VBN
that/IN
IFNAR1/NN
expression/NN
is/VBZ
related/JJ
to/TO
the/DT
effectiveness/NN
of/IN
interferon/NN
therapy/NN
in/IN
hepatitis/NN
C/NN
virus/NN
(/(
HCV/NN
)/)
-associated/JJ
chronic/JJ
liver/NN
disease/NN
(/(
CLD/NN
)/)
(/(
Fukuda/NN
etal./FW
,/,
1996/CD
)/)
./.
====================
Furthermore/RB
,/,
it/PRP
was/VBD
also/RB
reported/VBD
that/IN
great/JJ
apes/NNS
could/MD
be/VB
infected/JJ
with/IN
human/JJ
hepatitis/NN
viruses/NNS
,/,
but/CC
usually/RB
do/VBP
not/RB
progress/VB
to/TO
cirrhosis/NN
or/CC
hepatocellular/JJ
carcinomas/NNS
as/IN
often/RB
seen/VBN
in/IN
human/JJ
(/(
Muchmore/RBR
et/FW
al./FW
,/,
1988/CD
)/)
./.
====================
Therefore/RB
,/,
it/PRP
would/MD
be/VB
====================
interesting/VBG
to/TO
examine/VB
a/DT
possibility/NN
that/IN
functional/JJ
consequences/NNS
of/IN
IFNAR1/NN
differences/NNS
may/MD
related/JJ
with/IN
the/DT
differences/NNS
in/IN
efficacy/NN
of/IN
interferon/NN
therapy/NN
or/CC
cirrhotic/JJ
progression/NN
in/IN
both/DT
the/DT
species/NNS
during/IN
chronic/JJ
hepatitis/NN
C/NN
virus/NN
infection/NN
./.
====================
Although/IN
the/DT
establishment/NN
of/IN
biological/JJ
significance/NN
of/IN
human/JJ
specific/JJ
variations/NNS
has/VBZ
a/DT
long/JJ
way/NN
to/TO
go/VB
,/,
this/DT
kind/NN
of/IN
genomic/JJ
change/NN
might/MD
be/VB
the/DT
most/JJS
important/JJ
in/IN
the/DT
development/NN
of/IN
human/JJ
traits/VBZ
./.
====================
Human/JJ
specific/JJ
traits/NNS
,/,
such/JJ
as/IN
those/DT
changes/NNS
in/IN
IFNAR1/NN
may/MD
contribute/VB
to/TO
distinctive/JJ
biological/JJ
properties/NNS
of/IN
immune-/NN
response/NN
to/TO
pathogens/NNS
and/CC
specific/JJ
adaptations/NNS
in/IN
the/DT
human/JJ
lineage/NN
./.
====================
In/IN
this/DT
study/NN
,/,
we/PRP
showed/VBD
that/IN
human/JJ
IFNAR1/NN
has/VBZ
3/CD
base/NN
pair/NN
deletion/NN
in/IN
genomic/JJ
DNA/NN
,/,
compared/VBN
with/IN
chimpanzee/NN
ortholog/NN
./.
====================
As/IN
a/DT
consequence/NN
,/,
human/JJ
IFNAR1/NN
may/MD
adopt/VB
a/DT
characteristic/JJ
structure/NN
distinct/JJ
from/IN
chimpanzee/NN
IFNAR1/NN
and/CC
this/DT
human/JJ
specific/JJ
trait/NN
could/MD
contribute/VB
to/TO
specific/JJ
immune/JJ
response/NN
in/IN
the/DT
most/JJS
optimized/VBN
manner/NN
for/IN
humans/NNS
./.
====================
Further/RB
molecular/JJ
biological/JJ
studies/NNS
on/IN
the/DT
IFNAR1/NN
will/MD
help/VB
us/PRP
to/TO
gain/VB
insights/NNS
into/IN
the/DT
molecular/JJ
implication/NN
of/IN
species/NNS
specific/JJ
host-pathogen/NN
====================
interaction/NN
in/IN
primate/JJ
evolution/NN
./.
====================
